Gluten content of Australian pharmaceutical products

The treatment of patients with coeliac disease is based on the strict avoidance of gluten. Such patients may be at risk if they ingest inadvertently pharmaceutical products that contain gluten. This paper provides information on the gluten content of Australian pharmaceutical products. It is recommended that legislation be introduced to require that excipients in pharmaceutical products which are known to be potentially hazardous to susceptible individuals be listed on the product label, possibly in code form.